loader
Please Wait
Applying Filters...

Euroapi Company Header Euroapi Company Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Maralixibat Chloride, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Maralixibat Chloride

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    GLOBAL SALES INFORMATION

    PATENTS

    DIGITAL CONTENT

    PharmaCompass

    Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.

    One Pharma aims to be one of the leading generic companies in Europe.

    2D Structure
    1. Also known as: Lopixibat chloride, 228113-66-4, Lum-001, Maralixibat chloride [usan], Lum001, Maralixibat (chloride)
    Molecular Formula
    C40H56ClN3O4S
    Molecular Weight
    710.4  g/mol
    InChI Key
    POMVPJBWDDJCMP-RUKDTIIFSA-M
    FDA UNII
    V78M04F0XC
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (4R,5R)-5-[4-[[4-(4-aza-1-azoniabicyclo[2.2.2]octan-1-ylmethyl)phenyl]methoxy]phenyl]-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-16-benzothiepin-4-ol;chloride
    2.1.2 InChI
    InChI=1S/C40H56N3O4S.ClH/c1-5-7-19-40(20-8-6-2)30-48(45,46)37-18-15-34(41(3)4)27-36(37)38(39(40)44)33-13-16-35(17-14-33)47-29-32-11-9-31(10-12-32)28-43-24-21-42(22-25-43)23-26-43;/h9-18,27,38-39,44H,5-8,19-26,28-30H2,1-4H3;1H/q+1;/p-1/t38-,39-;/m1./s1
    2.1.3 InChI Key
    POMVPJBWDDJCMP-RUKDTIIFSA-M
    2.1.4 Canonical SMILES
    CCCCC1(CS(=O)(=O)C2=C(C=C(C=C2)N(C)C)C(C1O)C3=CC=C(C=C3)OCC4=CC=C(C=C4)C[N+]56CCN(CC5)CC6)CCCC.[Cl-]
    2.1.5 Isomeric SMILES
    CCCCC1(CS(=O)(=O)C2=C(C=C(C=C2)N(C)C)[C@H]([C@H]1O)C3=CC=C(C=C3)OCC4=CC=C(C=C4)C[N+]56CCN(CC5)CC6)CCCC.[Cl-]
    2.2 Other Identifiers
    2.2.1 UNII
    V78M04F0XC
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. (4r,5r)-5-(4-((4-(4-aza-1-azoniabicyclo(2.2.2)octan-1-ylmethyl)phenyl)methoxy)phenyl)-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2h-16-benzothiepin-4-ol

    2. Livmarli

    3. Maralixibat

    2.3.2 Depositor-Supplied Synonyms

    1. Lopixibat Chloride

    2. 228113-66-4

    3. Lum-001

    4. Maralixibat Chloride [usan]

    5. Lum001

    6. Maralixibat (chloride)

    7. V78m04f0xc

    8. 228113-66-4 (chloride)

    9. Livmarli

    10. Lum 001

    11. 4-aza-1-azoniabicyclo(2.2.2)octane, 1-((4-((4-((4r,5r)-3,3-dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl)phenoxy)methyl)phenyl)methyl)-, Chloride (1:1)

    12. Chembl17879

    13. (4r,5r)-5-[4-[[4-(4-aza-1-azoniabicyclo[2.2.2]octan-1-ylmethyl)phenyl]methoxy]phenyl]-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2h-1lambda6-benzothiepin-4-ol;chloride

    14. 1-(4-((4-((4r,5r)-3,3-dibutyl-7-(dimethylamino)-4-hydroxy-1,1-dioxido-2,3,4,5-tetrahydrobenzo[b]thiepin-5-yl)phenoxy)methyl)benzyl)-1,4-diazabicyclo[2.2.2]octan-1-ium Chloride

    15. Lopixibat Chloride [inn]

    16. Unii-v78m04f0xc

    17. Shp 625

    18. Schembl6336189

    19. Shp625

    20. Maralixibat Chloride (usan/inn)

    21. Dtxsid701337104

    22. Maralixibat Chloride [inn]

    23. Maralixibat Chloride [who-dd]

    24. Hy-16747

    25. Maralixibat Chloride [orange Book]

    26. Cs-0012347

    27. D10952

    28. Q27291628

    2.4 Create Date
    2006-10-25
    3 Chemical and Physical Properties
    Molecular Weight 710.4 g/mol
    Molecular Formula C40H56ClN3O4S
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count7
    Rotatable Bond Count13
    Exact Mass709.3680061 g/mol
    Monoisotopic Mass709.3680061 g/mol
    Topological Polar Surface Area78.5 Ų
    Heavy Atom Count49
    Formal Charge0
    Complexity1080
    Isotope Atom Count0
    Defined Atom Stereocenter Count2
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Indication

    Treatment of Progressive Familial Intrahepatic Cholestasis

    Treatment of Alagille syndrome

    Treatment of biliary atresia

    5 Pharmacology and Biochemistry
    5.1 FDA Pharmacological Classification
    5.1.1 Pharmacological Classes
    Ileal Bile Acid Transporter Inhibitors [MoA]; Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]; Ileal Bile Acid Transporter Inhibitor [EPC]
    5.2 ATC Code

    A - Alimentary tract and metabolism

    A05 - Bile and liver therapy

    A05A - Bile therapy

    A05AX - Other drugs for bile therapy

    A05AX04 - Maralixibat chloride

    Post Enquiry
    POST ENQUIRY